Migraine
885
105
135
516
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
210 trials with published results (24%)
Research Maturity
516 completed trials (58% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
4.9%
43 terminated out of 885 trials
92.3%
+5.8% vs benchmark
26%
227 trials in Phase 3/4
41%
210 of 516 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 516 completed trials
Clinical Trials (885)
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Effectiveness of Manual Lymphatic Drainage in the Physiotherapeutic Treatment of Migraine
Fremanezumab Managed Access Program for Pediatric Patients
A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents
App-based Breathing Program for Migraine Relief
Long-term Atogepant in Real-world Practice
Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine
Optical Coherence Tomography in Neurological Practice: Utility and Applicability Across Neurological Diseases (OCt.IN.N)
Default Mode Network Connectivity and Nocebo Responses in Migraine: A Functional MRI Study
Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
Headache Diary for Migraine Patients
Treatment for Migraine and Mood
A Clinical Trial Evaluated the Safety and Tolerability, Pharmacokinetic and Pharmacodynamics Profile, and Immunogenicity of a Single Dose of JS010 Injection in Healthy Subjects
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
Exploring the Effect of the Transcendental Meditation® Technique on Migraine Frequency, Intensity, and Functionality: A Single-Arm Study
Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine